Cingulate (CING) Expected to Announce Quarterly Earnings on Monday

Cingulate (NASDAQ:CING) is expected to be announcing its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($1.48) per share for the quarter.

Cingulate Stock Performance

Cingulate stock opened at $4.35 on Monday. The company’s 50-day moving average price is $4.28 and its 200-day moving average price is $4.45. Cingulate has a twelve month low of $1.80 and a twelve month high of $20.83.

Analysts Set New Price Targets

Several equities research analysts have weighed in on CING shares. Roth Mkm assumed coverage on Cingulate in a research note on Friday, January 10th. They set a “buy” rating and a $12.00 price objective on the stock. HC Wainwright reissued a “buy” rating and set a $20.00 target price on shares of Cingulate in a research report on Thursday, March 6th. Finally, Roth Capital upgraded Cingulate to a “strong-buy” rating in a research report on Friday, January 10th.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.